Cargando…

Ambovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Hepatocellular carcinoma (HCC) is a global public health problem, based on it being the fifth most common cancer and third leading cause of cancer-related mortality worldwide. The approved conventional treatment methods for HCC have shown life-threatening side effects with limited or negligible succ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salama, Hosny, Ahmad, Hassan, Elchagea, Ismail, Zekri, Abdel Rahman, Medhat, Eman, Bahnassy, Abeer, Lange, Michael, Rabbat, Mohammed, de la Torre, Andrew N, Punamiya, Pravin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918287/ https://www.ncbi.nlm.nih.gov/pubmed/27508197 http://dx.doi.org/10.2147/JHC.S60864

Ejemplares similares

Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
por: Salama, Hosny, et al.
Publicado: (2014)

The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2015)

Consensus siRNA for inhibition of HCV genotype-4 replication
por: Zekri, Abdel Rahman N, et al.
Publicado: (2009)

Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian study
por: Salama, Hosny, et al.
Publicado: (2012)

Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization
por: Aly, Magdy S., et al.
Publicado: (2010)

Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2018)

Potential Diagnostic and Prognostic Value of Lymphocytic Mitochondrial DNA Deletion in Relation to Folic Acid Status in HCV-Related Hepatocellular Carcinoma
por: Zekri, Abdel Rahman N, et al.
Publicado: (2017)

Cancer in Africa: Is It a Genetic or Environmental Health Problem?
por: Bahnassy, Abeer A., et al.
Publicado: (2020)

Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: Preliminary study
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2008)

Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2022)

The possible role of cell cycle regulators in multistep process of HPV-associated cervical carcinoma
por: Bahnassy, Abeer A, et al.
Publicado: (2007)

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016)

Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer
por: Khaled, Hussein M, et al.
Publicado: (2009)

MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2018)

Characterization of chronic HCV infection-induced apoptosis
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2011)

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010)

Assessment of the Circulating Tumor Cells and Microsatellite Instability in Colorectal Cancer Patients: Prognostic and Diagnostic Value
por: Alsayed, Aya, et al.
Publicado: (2021)

The Role of CYP2D6 Polymorphisms in Determining Response to Tamoxifen in Metastatic Breast Cancer Patients: Review and Egyptian Experience
por: Malash, Ibrahim, et al.
Publicado: (2020)

The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion
por: Bogan, Danielle, et al.
Publicado: (2017)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients
por: Bahnassy, Abeer A, et al.
Publicado: (2004)

The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt
por: Mohamed, Osama, et al.
Publicado: (2020)

Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2013)

Occult HBV infection among Egyptian hepatocellular carcinoma patients
por: Hassan, Zeinab K, et al.
Publicado: (2011)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

New insight into HCV E1/E2 region of genotype 4a
por: Hussein, Nehal, et al.
Publicado: (2014)

BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions
por: Sinha, Abhilasha, et al.
Publicado: (2016)

A case of synchronous double primary breast carcinoma and osteosarcoma: Mismatch repair genes mutations as a possible cause for multiple early onset malignant tumors
por: Ahmed, Hytham, et al.
Publicado: (2012)

MRI in detection of hepatocellular carcinoma (HCC)
por: Digumarthy, Subba R, et al.
Publicado: (2005)

Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)

The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study
por: N Zekri, Abdel-Rahman, et al.
Publicado: (2020)

Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience
por: Youssef, Amira Salah El-Din, et al.
Publicado: (2022)

miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma
por: Yacoub, Radwa Alaa, et al.
Publicado: (2016)

Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4
por: Zekri, Abdel Rahman N, et al.
Publicado: (2007)

Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer
por: BAHHNASSY, ABEER, et al.
Publicado: (2015)

The Possible Role of Adipokines in HCV Associated Hepatocellular Carcinoma
por: El-Daly, Usama M, et al.
Publicado: (2020)

Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2014)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bm10dcqucu5f4pl5oi5ahqeeu2